Illumina Innovation Fund I has held a final close at $230 million, surpassing its initial target of $200 million. The firm’s debut vehicle focuses exclusively on genomics and precision medicine.
Illumina Ventures raises $230m
The US venture capital firm closes inaugural fund above target.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: